États-Unis - anglais - NLM (National Library of Medicine)

nexgen pharma, inc - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - ursodiol is a bile acid available as 200 mg and 400 mg capsules suitable for oral administration. ursodiol (ursodesoxycholic acid), is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. it is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water. the chemical name for ursodiol is 3α,7β-dihydroxy-5β-cholan-24-oic acid (c24 h40 o4 ). ursodiol has a molecular weight of 392.57. its structure is shown below: inactive ingredients: silicon dioxide, magnesium stearate, and corn starch. gelatin capsules contain gelatin and titanium dioxide and are printed with edible black ink; additionally, the 400 mg capsule also contains fd&c yellow #6 and d&c yellow #10.

États-Unis - anglais - NLM (National Library of Medicine)

intra-sana laboratories - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - reltone™ is a bile acid available as 200 mg and 400 mg capsules suitable for oral administration. ursodiol (ursodesoxycholic acid) is a naturally occurring bile acid found in small quantities in normal human bile and in the bile of certain other mammals. it is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water. the chemical name for ursodiol is 3α,7β-dihydroxy-5β-cholan-24-oic acid (c24 h40 o4 ). ursodiol has a molecular weight of 392.57. its structure is shown below: inactive ingredients: silicon dioxide, magnesium stearate, and corn starch. gelatin capsules contain gelatin and titanium dioxide and are printed with edible black ink; additionally, the 400 mg capsule also contains fd&c yellow #6 and d&c yellow #10.

États-Unis - anglais - NLM (National Library of Medicine)

fh2 pharma llc - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - ursodiol is a bile acid available as 200 mg and 400 mg capsules suitable for oral administration. ursodiol (ursodesoxycholic acid), is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. it is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water. the chemical name for ursodiol is 3α,7β-dihydroxy-5β-cholan-24-oic acid (c24 h40 o4 ). ursodiol has a molecular weight of 392.57. its structure is shown below: inactive ingredients: silicon dioxide, magnesium stearate, and corn starch. gelatin capsules contain gelatin and titanium dioxide and are printed with edible black ink; additionally, the 400 mg capsule also contains fd&c yellow #6 and d&c yellow #10.

États-Unis - anglais - NLM (National Library of Medicine)

lgm pharma solutions, llc - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - - ursodiol is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. safety of use of ursodiol beyond 24 months is not established. - ursodiol is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss. - ursodiol will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. hence, patients with such stones are not candidates for ursodiol therapy. - patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula are not candidates for ursodiol therapy. - allergy to bile acids.

États-Unis - anglais - NLM (National Library of Medicine)

cho-a pharm.co.,ltd. - bisacodyl 5 mg, docusate sodium 16.75 mg - laxative for temporary relief of occasional constipation and irregularity

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodeoxycholic acid lapl (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: magnesium stearate; maize starch; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; gelatin; sodium lauryl sulfate - ursodeoxycholic acid lupin (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule - excipient ingredients: silicon dioxide; gelatin; titanium dioxide; maize starch; magnesium stearate - ursodeoxycholic acid is indicated in the treatment of chronic cholestatic liver diseases.

Irlande - anglais - HPRA (Health Products Regulatory Authority)

strides pharma (cyprus) limited - ursodeoxycholic acid - capsule, hard - 250 milligram(s) - bile acid preparations; ursodeoxycholic acid